ProCE Banner Activity

Modern JAKi Strategies in Individualized Myelofibrosis Management: Insights from Community Oncologists Following Participation in Collaborative Learning Workshops

PDF

Download this resource to see key insights from community oncologists who participated in our small group workshops on the optimal use of JAK inhibitor therapy for patients with myelofibrosis. 

Released: November 11, 2024

Expiration: November 10, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from CTI BioPharma Corp., a Sobi Company; and Incyte Corporation.

CTI BioPharma Corp., a Sobi Company

Incyte Corporation